GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021)
GeneDx Holdings (WGS) reported Preferred Stock Liabilities of $334.4 million for Q2 2021, up 54.04% year-over-year from $217.1 million in Q2 2020, and little changed quarter-over-quarter from $334.4 million in Q1 2021.
GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
GeneDx Holdings (WGS) has 2 years of Preferred Stock Liabilities data on file, last reported at $334.4 million in Q2 2021.
- Preferred Stock Liabilities for Q2 2021 came in at $334.4 million, up 54.04% year-over-year; the trailing twelve-month figure through Jun 2021 was $334.4 million (up 54.04% YoY), and the FY2020 annual result was $334.4 million, up 54.04% from the prior year.
- Preferred Stock Liabilities held at $334.4 million in Q2 2021 per WGS's latest filing, from $334.4 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $334.4 million in Q3 2020 and troughed at $217.1 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 334.44 Mn |
| Mar 31, 2021 | 334.44 Mn |
| Dec 31, 2020 | 334.44 Mn |
| Sep 30, 2020 | 334.44 Mn |
| Jun 30, 2020 | 217.12 Mn |